Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations

v2.4.0.8
Consolidated Statements of Operations (USD $)
 3 Months Ended 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Consolidated Statements of Operations [Abstract]        
Net sales $ 127,821   $ 127,821  
Grant and other revenue 67,456 60,000 67,456 71,931
Total revenue 195,277 60,000 195,277 71,931
Cost of goods sold 105,438   105,438  
Gross profit 89,839 60,000 89,839 71,931
Operating expenses:        
Research and development 4,376,833 2,476,113 8,016,590 6,419,827
Selling, general and administrative 4,169,437 2,970,837 7,533,927 5,545,467
Total operating expenses 8,546,270 5,446,950 15,550,517 11,965,294
Loss from operations (8,456,431) (5,386,950) (15,460,678) (11,893,363)
Other income (expense):        
Interest income 1,962 8,170 3,459 17,903
Interest expense (465,268) (321,405) (828,350) (615,076)
Loss on extinguishment of debt (1,372,266)   (1,372,266)  
Change in derivative liabilities   (92,805)   (276,889)
Other, net (8,348) (41,832) 16,465 (56,469)
Total other expense, net (1,843,920) (447,872) (2,180,692) (930,531)
Net loss (10,300,351) (5,834,822) (17,641,370) (12,823,894)
Preferred stock dividends   (25,000)   (50,000)
Net loss attributable to common stockholders $ (10,300,351) $ (5,859,822) $ (17,641,370) $ (12,873,894)
Loss per common share (basic and diluted) $ (0.09) $ (0.06) $ (0.15) $ (0.14)
Weighted average shares outstanding (basic and diluted) 118,260,288 94,664,659 116,024,366 94,368,690